Fumaric Acid

Fumaric Acid

SCHEMBL747023

CN1C2CCC1CC(Oc1ccc(-c3ccc4[nH]c(C(F)(F)F)cc4c3)nc1)C2.O=C(O)/C=C/C(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KCNH2 known ✓ Q12809 4/20 0.47
SLC6A2 known ✓ P23975 1/20 0.35
CHRNA7 P36544 4/20 0.47
DGAT1 O75907 6/20 0.41
P2RX3 P56373 1/20 0.37
P2RX2 Q9UBL9 1/20 0.37
CYP3A4 P08684 1/20 0.37
TTK P33981 1/20 0.37
AURKB Q96GD4 1/20 0.37
INCENP Q9NQS7 1/20 0.37
OPRK1 P41145 1/20 0.36
SOS1 Q07889 1/20 0.36
SLC6A3 Q01959 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL748372 0.92 KCNH2 (0.53) CHRNA7KCNH2DGAT1P2RX3P2RX2
Trifluoroacetic Acid SCHEMBL747090 0.79 CHRNA7 (0.51) CHRNA7KCNH2DGAT1CYP3A4TTK
Trifluoroacetic Acid SCHEMBL744720 0.78 CHRNA7 (0.47) CHRNA7KCNH2DGAT1CYP3A4
SCHEMBL747024 0.77 P2RX3 (0.36) DGAT1P2RX3P2RX2CYP3A4TTK
SCHEMBL744341 0.77 CHRNA7 (0.49) CHRNA7KCNH2SLC6A2SLC6A3
SCHEMBL2484828 0.77 CHRNA7 (0.49) CHRNA7KCNH2SLC6A2SLC6A3
SCHEMBL2484827 0.77 CHRNA7 (0.49) CHRNA7KCNH2SLC6A2SLC6A3
SCHEMBL746894 0.77 CHRNA7 (0.57) CHRNA7KCNH2SOS1SLC6A2SLC6A3
SCHEMBL16136701 0.76 CHRNA7 (0.50) CHRNA7KCNH2P2RX3P2RX2OPRK1
SCHEMBL744858 0.76 KCNH2 (0.56) CHRNA7KCNH2DGAT1SOS1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431368-B1 CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBVIE BAHAMAS LTD (BS) 2014-08-27 EP disclosed
EP-2431368-A1 CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives Abbott Laboratories (US) 2012-03-21 EP disclosed
EP-2018380-B1 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LAB (US) 2011-10-19 EP disclosed
US-7872017-B2 Fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LABORATORIES (US) 2011-01-18 US disclosed
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives ABBOTT LABORATORIES (US) 2010-12-02 US disclosed
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES ABBVIE INC. 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES MALT1, BMP2, ALKBH2 KCNH2 708/4885SLC6A2 2602/4885CHRNA7 2776/4885
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives MALT1, BMP2, ALKBH2 KCNH2 708/4885SLC6A2 2602/4885CHRNA7 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.